Peripheral Blood Stem Cell Transplantation
"Peripheral Blood Stem Cell Transplantation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transplantation of PERIPHERAL BLOOD STEM CELLS. It is a less invasive alternative to direct marrow harvesting of hematopoietic stem cells. Enrichment of stem cells in peripheral blood can be achieved by inducing mobilization of stem cells from the BONE MARROW.
| Descriptor ID |
D036102
|
| MeSH Number(s) |
E02.095.147.500.500.500.500 E04.936.225.687.500.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Peripheral Blood Stem Cell Transplantation".
Below are MeSH descriptors whose meaning is more specific than "Peripheral Blood Stem Cell Transplantation".
This graph shows the total number of publications written about "Peripheral Blood Stem Cell Transplantation" by people in this website by year, and whether "Peripheral Blood Stem Cell Transplantation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 1 | 2 |
| 2007 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 4 | 0 | 4 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 1 | 2 |
| 2017 | 1 | 1 | 2 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2023 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Peripheral Blood Stem Cell Transplantation" by people in Profiles.
-
Clonal hematopoiesis and subsequent venous thromboembolism among survivors of autologous transplantation for lymphoma. J Natl Cancer Inst. 2025 Nov 01; 117(11):2394-2398.
-
Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma. J Clin Oncol. 2024 Jul 10; 42(20):2415-2424.
-
Impact of stem cell selection between bone marrow and peripheral blood stem cells for unrelated hematopoietic stem cell transplantation for hematologic malignancies: on behalf of the Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy. Cytotherapy. 2024 02; 26(2):178-184.
-
Factors Impacting Time to Engraftment in Patients With High-risk Neuroblastoma Following Autologous Stem Cell Transplant. J Pediatr Hematol Oncol. 2020 10; 42(7):e569-e574.
-
Feasibility and efficacy of low-dose pegfilgrastim for CD34+ cell mobilization in lymphoma. J Clin Apher. 2020 Sep; 35(5):413-419.
-
Severe Cytokine Release Syndrome after Haploidentical Peripheral Blood Stem Cell Transplantation. Biol Blood Marrow Transplant. 2019 12; 25(12):2431-2437.
-
[Early relapse after autologous peripheral blood stem cell transplantation in an elderly patient with enteropathy-associated T-cell lymphoma]. Rinsho Ketsueki. 2018; 59(7):889-894.
-
Synchronous Central Nervous System Atypical Teratoid/Rhabdoid Tumor and Malignant Rhabdoid Tumor of the Kidney: Case Report of a Long-Term Survivor and Review of the Literature. World Neurosurg. 2018 Mar; 111:6-15.
-
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Multiple Myeloma. Biol Blood Marrow Transplant. 2017 Nov; 23(11):1903-1909.
-
Value of surgical resection in children with high-risk neuroblastoma. Pediatr Blood Cancer. 2015 Sep; 62(9):1529-35.